AN2 Therapeutics, Inc.【ANTX】
Market cap
$141.52M
P/E ratio
| Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Research and development | 29 | 55 | 40 |
| General and administrative | 13 | 15 | 14 |
| Restructuring charges | - | - | 2 |
| Total operating expenses | 42 | 70 | 57 |
| Loss from operations | -42 | -70 | -57 |
| Interest income | - | - | 5 |
| Other income | -0 | 5 | - |
| Net loss | -43 | -65 | -51 |
| Earnings Per Share, Basic | -2.79 | -2.74 | -1.72 |
| Earnings Per Share, Diluted | -2.79 | -2.74 | -1.72 |
| Unrealized (loss) gain on investments | -0 | 1 | -0 |
| Comprehensive loss | -41 | -64 | -52 |